A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

692

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

June 27, 2018

Study Completion Date

October 30, 2018

Conditions
Knee Osteoarthritis
Interventions
DEVICE

HL-01: high and low molecular weight hyaluronic acid

2 ml intra-articular single injection

DEVICE

Placebo

2 ml intra-articular single injection

Trial Locations (31)

Unknown

CHU Centre Ville (Brull) - Bone Metabolism Unit, Liège

Rheumazentrum Prof. Dr. med. Gunther Neeck, Bad Doberan

Klinische Forschung Berlin-Mitte GmbH, Berlin

DGS Schmerzzentrum Eichstätt, Eichstätt

AmBeNet GmbHDas Ambulante BehandlungsNetz, Leipzig

Revita Rendelő, Budapest

Semmelweis Egyetem - Ortopediai Klinika, Budapest

Szent Margit Rendelőintézet, Budapest

DEEK University, Debrecen

MEDIDEA Egeszsegugyi es Szolgaltato Beteti Tarsasag, Kiskunfélegyháza

Swan Med SMO, Létavértes

Istituto Ortopedico Gaetano Pini, Milan

Fisiatria Policlinico di Napoli, Napoli

Ospedale San Pietro - FATEBENEFRATELLI, Roma

NZOZ VITAMED Gałaj i Cichomski Sp. j., Bydgoszcz

ETG Chełm, Chełm

Centrum Medyczne Lukamed, Chojnice

Centrum Kliniczno-Badawcze, Elblag

Gdańskie Centrum Zdrowia, Gdansk

ETG Łódź, Lodz

Klinika Zdrowej Kości, Lodz

ETG Lublin, Lublin

SOLB - Zbigniew Zegota, Ostróda

ETG Siedlce, Siedlce

RCMed, Sochaczew

ETG Warszawa, Warsaw

Europejskie Centrum Leczenia Chorób Cywilizacyjnych, Warsaw

NZOZ Wilmed, Warsaw

Wasilczyk Medical Clinic Indywidualna Praktyka Lekarska Cezary Wasilczyk, Warsaw

ETG Zamość, Zamość

21-040

Lubelskie Centrum Diagnostyczne, Świdnik

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT03200288 - A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter